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1. Introduction 
Electronic pacemaker, since its invention over five decades ago, has saved numerous lives 
and improved the life quality of patients suffering from cardiac arrhythmias. However, it 
has its own limitations. Over the past decade, rapid progress in the molecular studies of 
cardiac ion channels and stem cell biology has led to efforts for creating a biological 
pacemaker to supplement the widely used electronic pacemaker. We focus on the 
development of the ideas for creating a working biological pacemaker. The gene-based and 
cell-based approaches to meet the requirements of a working biological pacemaker will be 
reviewed. The important roles of the hyperpolarization-activated cyclic, nucleotide-
modulated (HCN) channels, the inward rectifier Kir2.1 potassium channels, and the gap 
junctions in the biological pacemaker system will be discussed. Finally, recent development 
of cell-based strategy and precautions for creation of an effective biological pacemaker 
superior to the electronic counterpart will also be discussed. 
2. Hierarchic organization of cardiac pacemakers 
Throughout life, the heart beats close to 3 billion times (assuming 70 beats per minute with a 
mean life span of 80 years). The ability of the heart to beat spontaneously and continuously 
relies on its highly organized pacemaker system. 
The cardiac pacemaker activity is originated in the sinoatrial node (SAN) located in the right 
atrium. The electrical impulses are transmitted to the atria, then the atria-ventricular (AV) 
node to the His/Purkinje conducting system, and to the working ventricles. 
Pacemaker activity has also been found in regions outside the SA node, including atria, AV 
node, and Purkinje fibers. Under physiologic conditions, these regions have much slower 
intrinsic pacing rates, and thus are overdriven by the SA node. Pacemaker activity is absent 
in the adult mammalian ventricle, but is present in the cultured newborn ventricle. 
Abnormal pacemaker activity also appears in cardiomyopathies such as heart failure and 
hypertrophy. 
Heart rate is subject to autonomic regulation. Sympathetic stimulation accelerates heart rate 
by activating β adrenergic receptors, whereas parasympathetic stimulation slows heart rate 
by activating muscarinic acetylcholine receptors. Through the G-protein/adenylate cyclase 
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pathway, autonomic stimulation alters the intracellular cAMP levels, which in turn, changes 
the heart rate by altering the gating properties of membrane transporters including ion 
channels, exchangers and pumps. Increased cAMP levels enhance, while decreased cAMP 
levels reduce, the heart rate. 
2.1 Cardiac pacemaker activity generation 
Cardiac pacemaker activity begins with the diastolic (phase-4) depolarization, which is a 
slow time-dependent depolarizing process different from the rapid action potential firing 
(Figure 1). The major ionic mechanisms for the initiation of this diastolic depolarization have  
 
 
Fig. 1. Action potentials recorded from single myocytes isolated from rabbit SA node (A), 
canine Purkinje fiber (B), and canine ventricle. Current stimulus was used to generate action 
potentials in Purkinje and ventricular myocytes. 
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been debated for nearly three decades (Brown et al., 1979; DiFrancesco, 1995; Vassalle, 1995; 
Liu et al., 1998; Lipsius & Bers, 2003; Bers, 2006; Sanders et al., 2006; Lakatta & DiFrancesco, 
2009; DiFrancesco, 2010; Lakatta, 2010), reflecting the complex nature of this essential 
biological function. Despite its complicated mechanism, there is a widely accepted 
agreement that a net inwardly increasing current (net positive ions entering the cell) must 
contribute to this process. The minimal requirement for producing such a net inward current 
could be a combination of either a time-dependent outward current and a constant inward 
background current, or a time-dependent inward current and a time independent outward 
background current (Vassalle et al., 1999).  With regard to the biological pacemaker, we will 
mainly focus on the discussion of the latter combination. This, by no means, undermines 
other mechanisms such as Ca2+ clocks that also play important roles in cardiac pacemaker 
activity (Lakatta et al., 2008; Lakatta & DiFrancesco, 2009; Lakatta et al., 2010).   
2.2 Action potentials and membrane currents of cardiac myocytes 
Cardiac pacemaker activity is tissue-specific. Spontaneous action potentials can be readily 
recorded in single myocytes isolated from SA node (Figure 1, upper panel), but harder from 
isolated Purkinje myocytes. However, with current stimulus, phase-4 depolarization can be 
elicited in isolated Purkinje cells (Figure 1, middle panel). In isolated ventricular myocytes, 
phase-4 depolarization cannot be induced with stimulus under physiological conditions 
(Figure 1, lower panel). According to Ohm’s law, these differential action potentials in 
different regions of the heart indicate different underlying ionic mechanisms. Figure 2 
shows the membrane currents near the end of repolarization that are different in primary 
pacemaker tissue (SA node), conducting system (Purkinje fibers), and working ventricles. In 
response to a hyperpolarizing pulse to the indicated voltages, in the SA node, there is a 
strong time-dependent inward current, but little background potassium outward current, 
indicated by the lack of an instant jump at the beginning of the hyperpolarizing pulse 
(upper panel); in the Purkinje cells, in additional to the time-dependent inward current, 
there is a considerable amount of background potassium current (middle panel); in the 
ventricular myocytes, the background outward current is dominant with little time-
dependent inward current (lower panel). 
It is noted that if the time independent outward current is so small that it can be negligible, 
such as in the SA node, inducing diastolic depolarization requires only a few pA of time-
dependent inward current (Vassalle et al., 1999). On the other hand, if the time-dependent 
background outward current is large, a much larger time-dependent inward current is 
needed to initiate diastolic depolarization, such as in the Purkinje fibers (Figure 2, middle 
panel). Once the time independent outward current dominates over the time dependent 
inward current, diastolic depolarization cannot be elicited, which is the case in the ventricle 
(Figure 2, lower panel). Thus, generation and inhibition of diastolic depolarization can be 
achieved by adjusting the expression levels of the time independent outward current 
and/or the time dependent inward current. 
3. Hyperpolarization-activated HCN, inward rectifier Kir2.x potassium 
channels, and gap junction channels in the sinus node and in the ventricles 
Action potential is an electrical process that reflects the time dependent changes in charges 
across the cell membrane. Due to uneven distribution of ions inside and outside of the cell, 
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ions crossing the cell membrane via ion channels alter the membrane potential in a dynamic 
manner. The time- and voltage-dependent inward current (e.g., Na+ current) makes the 
membrane more positive (or less negative), whereas the time- and voltage-dependent 
outward current (e.g., K+ current) drives the membrane potential toward more negative 
values. The delicate balance of inward and outward currents initiates and maintains the 
rhythmic heart beat under physiological conditions. Disruption of this ionic balance 
predisposes the heart to arrhythmias (irregular heart beat). 
In this chapter, we focus on the properties of two ionic currents, the hyperpolarization-
activated cation current, If, and the inward rectifier potassium current, IK1. We also describe 
the gap junction channels in the heart due to their critical roles in electrically connecting the 
myocytes to produce synchronous cardiac contraction. 
3.1 If and HCN channels 
If is an important contributor to the cardiac pacemaker activity. Opened by 
hyperpolarization near the end of repolarization in the sinus node, If contributes 
significantly to the diastolic (phase-4) depolarization, which leads to the threshold of Ca-
channel activation and firing of an action potential. 
Unlike most voltage-gated ion channels that are activated by membrane depolarization, If is 
activated by membrane hyperpolarization at the end of repolarization (Figure 2, Figure 4B). 
If channels pass Na+ and K+ ions (DiFrancesco, 1993) and a tiny amount of Ca2+ ions (Yu et 
al., 2004; Yu et al., 2007). Under physiological conditions, mainly Na+ ions go in and much 
less K+ ions come out through the channel near maximum diastolic potential (MDP) (e.g., -
60mV to -90mV), generating a time dependent inward current with a reversal potential 
around –20mV (DiFrancesco, 1993). 
The threshold activation of If is closely associated with the tissue pacemaker activity. In the 
SA node, If activates near -50mV and the MDP is around -65mV (upper panels in Figures 
1&2). In Purkinje fibers, If activates around -70mV and the MDP is near -85mV (middle 
panels in Figures 1&2). In the ventricle, If activates at potentials more negative than -100mV 
(Yu et al., 1993, 1995; Robinson et al., 1997), and the MDP is around -90mV (lower panels in 
Figures 1&2). 
In adult mammalian ventricles, the threshold activation of If in ventricular myocytes is also 
species specific. It is extremely negative in guinea pig ventricles (more negative than -
140mV) and a little more positive in canine ventricles (around -120mV) (Yu et al., 1993, 
1995). In rat ventricles, there are varying results with regard to If activation. Early studies 
showed a -110mV threshold activation of If in myocytes isolated from 3-month old rat 
ventricles (Robinson et al., 1997). However, more positive threshold activation of If in rat 
ventricles within the physiological voltages has been reported in several other studies 
(Cerbai et al., 1994, 1996; Ranjan et al., 1998; Xiao et al., 2007). It has been hypothesized that 
the potential contribution of If to the diastolic depolarization is masked by a large IK1 in the 
ventricular myocytes (see below). 
In the newborn ventricles, If activates around -70mV (Robinson et al., 1997). Diseased adult 
ventricles also increases If and shifts its threshold activation into the physiological voltages, 
near -55mV (Cerbai et al., 1997; Cerbai & Mugelli, 2006). The molecular basis of this 
developmental and disease modulated voltage dependent activation remains unclear. 
If is generated by HCN channels. Among the four isoforms that have been identified, three 
of them (HCN1, HCN2, HCN4) are differentially expressed in various regions of the heart. 
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Fig. 2. Membrane currents recorded in single myocytes isolated from rabbit SA node (upper 
panel), canine Purkinje fibers (middle panel), and canine ventricle (lower panel). The 
holding potential was -35mV for SA node myocyte, and -50mV for Purkinje and ventricular 
myocytes. The hyperpolarizing pulse was applied to -65mV (SA node), -75mV (Purkinje), 
and -90mV (ventricle), respectively. 
HCN total transcripts levels are the highest in the SA node, intermediate in the Purkinje 
fibers, and the lowest in the working ventricles (Shi et al., 1999; Shi et al., 2000). HCN4 is the 
dominant isoform in the SA node, representing about 80% of the total HCN transcripts. 
Equal amounts of HCN1 and HCN4 are present in the Purkinje fibers. In the ventricles, 
HCN2 expression levels are higher than HCN4, and no HCN1 has been detected (Shi et al., 
1999; Shi et al., 2000; Han et al., 2002). 
When expressed in the heterologous expression systems (Xenopus oocytes, mammalian 
culture cells such as HEK and COS cells), HCN1, HCN2, and HCN4 channels displayed 
distinct properties. HCN1 activates at the least negative potential (near -50mV) associated 
with the fastest activation kinetics, mimicking the SA node If. HCN2 and HCN4 are 
activated at more negative potentials (-60mV to -80 mV) with much slower activation 
kinetics (Robinson & Siegelbaum, 2003). In addition, HCN1 is nearly insensitive to 
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intracellular cAMP, while HCN2 and HCN4 activation curves can be shifted to depolarizing 
potentials by cAMP for more than 10mV. Binding of cAMP to the cyclic nucleotide binding 
domain in the C-terminus facilitates the gating of HCN channels (Wainger et al., 2001). 
3.2 IK1 and Kir2.1 channels 
The inwardly rectifying potassium current, IK1, is essential in the resting phase of ventricular 
action potential. Its reversal potential is close to the resting membrane potential. IK1 channels 
pass more inward current at potentials more negative than the potassium reversal potential 
(EK), but much fewer outward current at potentials more positive than EK; in the range of -
40mV to 0mV, IK1 is negligibly small and close to zero (Dhamoon & Jalife, 2005). 
IK1 is nearly absent in the sinus node, making the resting potential more positive (around -
65mV) in comparison to that in the ventricular myocytes (around -86mV) (Fig. 1). The 
relatively depolarized membrane potential in the sinus node allows small but significant If 
inward current to slowly depolarize the membrane during diastole, which is critical in 
initiating the pacemaker activity (Figure 1, upper panel). In the ventricular myocytes, due to 
the presence of a large IK1 and low expression If, there is no diastolic depolarization under 
physiological conditions (Figure 1, lower panel). 
IK1 is nearly undetectable in neonatal rat ventricular myocytes that have spontaneous 
pacemaker activity (Sekar et al., 2009). Similarly, in failing ventricles IK1 is reduced 
(Beuckelmann et al., 1993). Meantime, If activity is increased in neonatal (Robinson et al., 
1997) and in failing ventricles (Cerbai et al., 1997; Hoppe et al., 1998). A combination of  
reduced IK1 and an increased If predisposes the ventricle to generate unwanted diastolic 
depolarization (Cerbai & Mugelli, 2006). 
IK1 is mainly produced by inward rectifier potassium Kir2.x (x=1,2,3,4) channels in the heart. 
In ventricular myocytes Kir2.1 is the predominant isoform, although Kir2.2 may also 
contribute to IK1 to some extent (Dhamoon & Jalife, 2005). Kir2.1 transcripts have been 
reported to be at the lower levels in the SA node and atria, but much higher in the ventricles 
(Gaborit et al., 2007). During cardiac development, Kir2.1 is also found at the lowest levels in 
the mice SA node (Schweizer et al., 2009). In neonatal rat ventricular myocytes, Kir2.1 
protein expression is barely detected (Sekar et al., 2009).  
For both HCN and Kir2.1 channels, tetramers are formed as the functional channels. 
Different HCN or Kir2.x channel isoforms may form the functional heteromeric channels 
generating native If or IK1 in the heart. 
3.3 Cardiac gap junction channels  
Gap junctions allow direct passage of ions and small signaling molecules with molecular 
weight up to ~1000 Daltons between adjacent cells. Gap junctions are required in the 
orchestrated electrical activation of the heart. Spontaneous action potentials generated from 
the SA node are efficiently transmitted to the working ventricles due to electrical coupling 
among the myocytes in different regions of the heart. The coordinated muscle contraction 
depends upon normal gating of gap junction channels between myocytes.  
Gap junctions are formed by two hemi-channels (connexons) with each expressed on the 
plasma membrane of adjacent myocytes. Each hemi-channel is assembled by six connexins 
(Cx) spanning the plasma membrane (Yeager, 1998). Their extracellular domains form the 
gap junction with their N- and C-termini in the intracellular space for channel regulation.  
There are three main connexins identified in the heart: Cx40, Cx43, and Cx45. They can form 
either homomeric or heteromeric connexins (Yeager, 1998). When expressed in the 
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heterologous expressing systems, they exhibit distinct single channel conductance that 
determines the propagation speed of electrical signals. Single channel conductance is large 
for Cx43 and Cx40, about 100pS and 158-198 pS, respectively, and small for Cx45, about 
30pS (Gonzalez et al., 2007). 
Gap junctions with large conductance facilitate fast transmission of electrical signals such as 
Purkinje fibers and working ventricles. Gap junctions with small conductance are mainly 
restricted in the pacemaker tissues such as the SA node and AV node in which the electrical 
transmission is slow. 
Cx43 is the dominant connexin in the working ventricles, co-expressed with Cx40 in atria, 
absent in the SA node and AV node. Cx45 is present in the atria including the SA node, AV 
node, His bundle and ventricles (Saez et al., 2003; Severs et al., 2008). All three connexins are 
present in Purkinje fibers (Severs et al., 2008). In the slow conducting tissues, such as the SA 
node and AV node, only Cx45 is expressed. Redistribution and reduction in cell surface 
expression of gap junctions have been linked to severe arrhythmias associated with ischemia 
and failing heart (Severs et al., 2008).  
4. Need for biological pacemaker 
When dysfunction of the SA node or blockade of the AV node occurs, generation of normal 
action potentials or the propagation of the normal electrical signals to the working ventricle 
is disrupted. The latent pacemakers in atria and Purkinje fibers will pace at their own rates 
(slower than the sinus rate). This creates an asynchronous rhythmic contraction of the heart 
muscle leading to a decreased blood pumping efficiency. It also predisposes the heart to 
more dangerous arrhythmias. To preserve the normal muscle contraction under SA node 
dysfunction, the standard surgical intervention is to implant an electronic pacemaker, which 
has become the industrial standard since its invention. 
While extremely successful and widely used as a life-saving device, the electronic 
pacemaker has its own limitations. They include 1) battery life; it usually needs to be 
replaced every 5-7 years; 2) implantation sites of the leads which may affect the cardiac 
output; 3) in growing children, pacemaker lead length is problematic requiring multiple 
replacements in pediatric patients; 4) lack of physiological response to autonomic 
stimulations in exercise, although software has been developed to improve responses to 
varying heart rate in exercise; 5) potentially increased risk of heart failure for long-term use; 
6) a separation of wires connecting the lead to the battery.  In responding to these 
challenges, creating a biological pacemaker has been emerged as a promising supplement. 
5. Implementation of biological pacemaker  
Cardiac action potential is finely maintained by a number of channels, pumps, and 
exchangers (Figure 3). For discussion of biological pacemaker, we focus on the roles of IK1 
and If currents that contribute to the membrane stability and diastolic depolarization.   
Differential expression of HCN and Kir2.x channels and distinct properties of If and IK1 
contribute to the different resting and action potentials in the sinus node and ventricular 
myocytes. As depicted in Figure 3, one of the characteristics in an electrically quiescent 
myocyte (such as a ventricular myocyte) is the abundant expression of IK1 and low 
expression of If. On the other hand, spontaneous myocytes (i.e., SA node cells) express high 
levels of If and no IK1. Gap junction channels are needed to connect these two different types 
of myocytes for pacing at the same rate. 
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Fig. 3. Schematic illustration of major ion channels in quiescent and spontaneous cardiac 
myocytes. GJ= gap junction. Dark filled channels, IK1 and If, are the focuses in quiescent and 
spontaneous myocytes. If, IK1, and gap junctions are essential requirements (among others) 
for enhancing, suppressing, and propagating the pacing activity throughout the entire heart. 
If in grey indicates much less physiological role in quiescent myocytes than in spontaneous 
myocytes. 
A combination of an absent IK1 and an activated If at diastolic potential sets up the stage for 
the cardiac pacemaker activity in the sinus node (Fig. 4B). On the other hand, large IK1 and 
small If with negative activation mask the spontaneous pacemaker activity in the ventricle 
(Fig. 4A). These principles have been used as a working guidance in the development of the 
biological pacemaker. Therefore, enhancing HCN channel activity or inhibiting Kir2.1 
channel activity or a combination of both should increase the spontaneous pacemaker 
activity in the ventricle.  
 
 
Fig. 4. Schematic illustration of roles for IK1 (dark) and If (grey) at diastolic depolarization of 
action potentials in a canine ventricular myocyte and in a spontaneous myocyte (e.g., rabbit 
sinus node cell). 
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Using a computer simulation of ventricular action potential (Figure 5), we had predicted 
that if IK1 conductance is reduced by 40% and the maximal conductance of If is increased by 
three-fold associated with a 40mV depolarized shift of the activation curve into the 
physiological voltages, the spontaneous pacemaker activity can be induced in the ventricles. 
These represent the minimal conditions to induce a ventricular spontaneous diastolic 
depolarization. In the past ten years the overexpression of either a dominant negative Kir2.1 
or HCN channels have successfully  induced spontaneous activity in the adult ventricular 
myocytes and in the hearts of intact animal models. The altered biophysical properties for 
both IK1 and If have far exceeded the simulation conditions shown in Figure 5. 
 
 
Fig. 5. Computer simulation of ventricular action potential using a Beeler and Reuter 
ventricular model (Beeler & Reuter, 1977). The parameters for IK1 and If were adjusted for 
minimal requirements to induce a ventricular pacing. If: maximal conductance. Shift: the 
voltage shift of the threshold activation. 
Manipulation of HCN and Kir2.1 gene expression is a gene-based strategy for creation of a 
biological pacemaker. An alternative approach, a cell-based strategy, is to use the cells that 
have already had the desired ion channels for pacing (e.g., sinus node cells) or cells that are 
able to differentiate into the desired myocytes (e.g., stem cells). The advantages and 
disadvantages of these two approaches will be discussed below. 
5.1 Gene-based approach 
5.1.1 Overexpression of β-adrenergic receptors 
The direct consequence of a sinus node dysfunction is the slow heart rate. Stimulation of β-
adrenergic receptor can increase heart rate by increasing If (Brown et al., 1979; DiFrancesco, 
1986). Early studies in late 1990s demonstrated that overexpression of the β-adrenergic 
receptors in mouse embryonic and neonatal ventricular myocytes increased pacing rate 
(Edelberg et al., 1998). Similar observation was made in a 6-week old intact mouse heart after 
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the right atria were injected with full-length β-adrenergic receptors plasmid (Edelberg et al., 
1998).  
The cellular and ionic mechanisms that mediate the positive chronotropic effect of β-
adrenergic receptors have been well documented. Stimulation of β-adrenergic receptors 
activates adenylate cyclase via G-proteins. Adenylate cyclase catalyzes ATP to cAMP which 
enhances If  activity (DiFrancesco, 1993; Vassalle et al., 1999). It is thus not surprising that 
overexpression of adenylate cyclase may also be able to pace the quiescent ventricle. 
5.1.2 Overexpression of adenylate cyclase 
In a pig AV-block model, Ruhparwar et al successfully converted the quiescent ventricular 
myocytes into the pacing cells near the injection site by overexpressing adenylate cyclase 
type VI (AC-VI) in the left ventricles (Ruhparwar et al., 2010). The main idea was to boost the 
intracellular levels of cAMP that significantly increases the gating of HCN channels. The 
AC-VI in adenoviral vector was delivered into the left ventricle of a porcine heart. After 12 
days, complete AV-block was induced by catheter ablation. After rapid ventricular pacing, 
an escape rhythm in the injection area was detected (Ruhparwar et al., 2010).  
Lack of normal ventricular diastolic depolarization is a result of large IK1 and small If. 
Although cAMP has been reported to cause a depolarizing shift of the If/HCN channel 
activation curves (DiFrancesco, 1986, 1993), it is unclear whether the dramatic increase of 
cAMP beyond the physiological level might also enhance the protein expression of HCN 
channels in the pig’s ventricles. Another possibility is that rapid ventricular pacing may up-
regulate HCN channel expression in the ventricle. A third possibility is that the basal level 
of intracellular cAMP is dramatically increased in AC-VI over-expressed ventricular 
myocytes (Ruhparwar et al., 2010).  Increased cAMP enhances the opening probability of 
HCN channels (Wainger et al., 2001). However, the expression levels of both HCN2 and 
HCN4 are low in the ventricles under physiological conditions. Lack of diastolic 
depolarization of ventricular myocytes is well explained by a large IK1 and non-
physiological threshold activation of If which are encoded by HCN2/HCN4 in the 
ventricles. Currently, it is unknown whether the dramatic increase in intracellular cAMP 
levels might also increase the functional HCN channels at the plasma membrane of the 
ventricular myocytes, which would make sense of converting quiescent ventricular 
myocytes into pacing myocytes by overexpression of AC-VI. Thus, how AC-VI 
overexpression is able to transform quiescent ventricular myocytes into spontaneously 
pacing myocytes remains an open question. 
Adult cardiac myocytes are well differentiated and difficult in taking up exogenous 
proteins. One common method is to use virus-mediated infection. The gene of interest 
(HCN or Kir2.1) is inserted into a viral vector and viral particles containing the gene of 
interest are generated. Infected ventricular myocytes exhibit the spontaneous pacemaker 
activity under the condition in which either the Kir2.1 channel activity is inhibited or HCN 
channel activity is enhanced. 
5.1.3 Inhibition of IK1 
The first evidence to demonstrate the feasibility of creating a biological pacemaker was to 
inhibit IK1 by overexpression of a dominant negative mutant of Kir2.1 (Kir2.1AAA) in guinea 
pig ventricular myocytes (Miake et al., 2002). IK1 was inhibited by nearly 80%, leading to an 
increase in the resting membrane potential, action potential duration, and an induction of 
phase-4 depolarization (Miake et al., 2002, 2003).   
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The idea of this approach is to remove IK1 suppression of the latent pacemaker activity for 
creation of a biological pacemaker in the quiescent adult ventricles. Later, studies have 
shown that strong inhibition of IK1 significantly reduced the membrane stability, and thus, 
can create large IK1 heterogeneity, which is pro-arrhythmogenic (Sekar et al., 2009). 
5.1.4 Enhancement of If 
In both human atrial and ventricular myocytes, If has been detected at the physiological 
voltages (Hoppe & Beuckelmann, 1998; Hoppe et al., 1998). Large IK1 suppresses the 
potential contribution of If to the pacemaker activity in these tissues. If reduced IK1 can 
unmask the pacemaker activity in ventricular myocytes as elegantly illustrated in the Kir2.1-
AAA work, enhanced If should also be able to achieve the same goal.  
HCN2 was first to be chosen to test an idea that overexpression of HCN2 in the adult 
ventricles can increase If activity leading to the spontaneous pacemaker activity. The reasons 
for choosing HCN2 among other HCN isoforms were HCN2’s intermediate activation 
kinetics and its strong response to cAMP (Robinson et al., 2006). HCN2 was overexpressed 
in the canine left atrium mediated by adenovirus (Qu et al., 2003). After sinus arrest was 
achieved by vagal stimulation, spontaneous rhythm was detected in the left atrium. If 
amplitude was found more than 100-fold larger in HCN2-overexpressed atrial myocytes 
compared to native atrial myocytes or green fluorescent protein infected atrial myocytes by 
immunohistochemistry and Western blots. This work proved that it is feasible to create 
spontaneous pacemaker activity by increasing If current even in the presence of a large IK1. 
In a later study adenovirus containing HCN2 was injected to canine left bundle-branch. 
After two days, ventricular escape rhythms were recorded by 24-hour ECG monitoring 
during vagal stimulation (Plotnikov et al., 2004). HCN2 overexpression was verified in the 
dissected tissues. The work provided strong evidence for a HCN2-based gene approach to 
induce a biological pacemaker within the left bundle-branch in the dog heart. 
HCN1 has also been tested for creation of a biological pacemaker. A HCN1 mutant in which 
the S3-S4 linker was shortened by deleting three residues (HCN1- ΔΔΔ) in favor of channel 
gating was used to create an artificial SA node in a porcine model (Tse et al., 2006). HCN1-
ΔΔΔ was first overexpressed in the left ventricle of guinea pig to demonstrate its ability to 
pace the otherwise quiescent ventricular myocytes. Large If with physiological activation 
and fast activation kinetics, mimicking the SA node If, were detected in the adult guinea pig 
ventricular myocytes. This was to compare with the small If with very negative threshold 
activation (Yu et al., 1993). The group then produced sinus node dysfunction by 
radiofrequency ablation to generate a sick sinus syndrome pig model (Tse et al., 2006). At 10 
to 14 days after injection of adenovirus containing HCN1-ΔΔΔ construct into the left atrial 
appendage, spontaneous atrial rhythm at a rate of 64 bpm was recorded. The advantage of 
using this HCN1 mutant is its fast activation kinetics similar to that of the native SA node If. 
A recent study used HCN4 to create a biological pacemaker in the left ventricles of the pigs 
via an adenoviral gene transfer method (Cai et al., 2007). In this research, one-month old pigs 
underwent catheter ablation for inducing a complete AV block after 3-4 days of adenoviral 
gene transfer of HCN4. ECG recordings detected idioventricular rhythm. HCN4 transcripts 
were not detected in non-infected ventricles, but abundantly expressed in Ad-HCN4 
infected ventricles. Accordingly, large If-like current was recorded in the myocytes isolated 
from the Ad-HCN4 infected ventricles. The threshold activation was around -60mV with 
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midpoint activation near -90mV. The If-like current activation curve was shifted to a more 
positive potential in response to 1μM isoproterenol, which was proposed as the cellular 
basis for the accelerated idioventricular rhythm (Cai et al., 2007). 
It is unclear why small If-like currents were also recorded in myocytes from saline treated 
ventricles of pigs with similar gating properties, presumably due to the presence of HCN2. If 
is encoded by both HCN2 and HCN4 in the ventricles (Shi et al., 1999; Stillitano et al., 2008). 
Recent evidence has shown that they can form heteromeric channels in vitro and in vivo 
producing an If with physiological activation (Much et al., 2003; Whitaker et al., 2007; Zhang 
et al., 2009).  
The respective roles for If and IK1 in the induced ventricular pacemaker activity have 
recently been evaluated in the guinea pig left ventricular myocytes overexpressing either 
HCN1-ΔΔΔ or Kir2.1 (Chan et al., 2009). It was found that If activity is correlated with the 
slope of phase-4 depolarization and the firing frequency as well as the APD90, whereas IK1 is 
correlated with APD90, but not the phase-4 slope and firing frequency (Chan et al., 2009). 
The If functioning as a determinant for the basal firing frequency has also been observed in 
the neonatal rat ventricular myocytes (Chan et al., 2010).   
5.1.5 Creation of biological pacemaker by channel engineering 
Recently, an alternative strategy has been used to create a biological pacemaker. Kv1.4 is a 
voltage dependent K+ channel which is not present in the ventricle. It was converted into a 
hyperpolarization-activated, cation non-selective channel using site-directed mutagenesis 
(R447N, L448A, R431I in the S4 segment, and G528S in the pore region) (Kashiwakura et al., 
2006). Adenovirus-mediated gene transfer of this mutant channel into the left ventricle of 
guinea pig induced ectopic pacemaker activity in otherwise quiescent ventricle. This work 
provided additional supporting evidence for the requirement of time-dependent inward 
current, not necessarily from HCN channels, for the diastolic depolarization leading to the 
induction of pacemaker activity in adult heart ventricles. 
5.2 Cell-based approach 
5.2.1 Naturally pacing myocytes 
Sinus node cells are natural cardiac pacemakers. The electrical impulses generated from the 
sinus node are transmitted to the neighboring atrial myocytes through gap junctions (Figure 
6, upper panel). A fundamental question is how a SA node cell can pace its neighboring 
atrial myocytes, despite of the less negative MDP in SA node than in atrial myocytes?  The 
upper panel in Figure 6 depicts a working principle (Robinson et al., 2006), assuming the 
coupled SA node and atrial myocyte pair is at rest. The more negative membrane potential 
of the atrial myocyte hyperpolarizes the coupled SA node cell, leading to activation of HCN 
channels. The HCN inward current is a depolarizing current, which can pass through the 
gap junction and depolarize the atrial myocyte. When the HCN current is large enough to 
depolarize the membrane toward a threshold for further activation of the Na+ channels, an 
action potential is fired in the atrial myocyte. After the SA node cell is depolarized, HCN 
channels will be deactivated. Thus, this working mechanism guarantees a depolarizing 
current only at diastole (Robinson et al., 2006). This working principle also outlines the 
minimal requirements for creating a cell-base biological pacemaker. First, the implanted 
cells should be able to produce depolarizing current at the end of repolarization (i.e., at 
diastole). It does not matter whether the depolarizing current is a result of an enhanced 
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HCN current or a reduced IK1 current, or some other currents. Second, the implanted cells 
must be electrically coupled with the host cell via gap junctions. Third, the depolarizing 
current should not be needed after the action potential is fired in both the implanted and the 
host cells. 
 
 
Fig. 6. Schematic illustration of using cell-based approach to deliver HCN channel genes 
into a ventricular myocyte. Upper panel: the native pacemaker cell (SA node cell) coupled to 
its adjacent myocyte (e.g., an atrial myocyte) for propagation of spontaneous action 
potentials via gap junction. Lower panel: engineered stem cell containing HCN channels to 
deliver HCN genes to a ventricular myocyte via formed gap junction for over-expression of 
HCN channels in the targeted myocyte. Reprinted with permission from (Rosen et al., 2004). 
In early 1990s, effort was made to first remove the SA node cells from a subject (the patient), 
then culture to generate a sufficient amount of healthy SA node cells, and finally implant 
these cells back to the right ventricle to provide pacing (King, 1992). This idea was to 
recreate a new working SA node in a new site. Although a great idea, the approach itself 
faced several challenges such as technical feasibility and working principles. First, growing 
adult human SA node cells to a critical mass represents a technical difficulty, although 
newborn rat SA node cells have been reported to culture for up to 4-5 days (Marvin et al., 
1984). Thus, feasibility of this approach is in question. Second, whether the reproduced SA 
nodal cells were able to form gap junctions with the ventricular myocytes was unclear. The 
native SA node cells are coupled with surrounding atrial cells through gap junctions. 
Without effective coupling between a spontaneous cell and a quiescent cell, the diastolic 
depolarization in the spontaneous cell cannot be transmitted to the quiescent cell for 
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triggering spontaneous pacing. Third, implantation in the right ventricle could represent a 
latent ectopic pacemaker that may trigger arrhythmia. 
The proof-of-concept for creating a cell-based working biological pacemaker was first 
reported by transplanting the isolated fetal canine atrial myocytes including sinus node cells 
into the adult canine left ventricles (Ruhparwar et al., 2002). After 3-4 weeks, atrial-
ventricular node was ablated by catheter and a ventricular escape rhythm from the 
transplantation site was recorded, driving the pace of the heart. The functional coupling 
between the host myocytes (adult canine left ventricular myocytes) and the donor myocytes 
(fetal canine atrial myocytes) was evident by expression of connexin 43 between the injected 
and recipient myocytes (Ruhparwar et al., 2002). 
Using pacing fetal myocytes as a potential biological pacemaker has been further tested in 
the porcine model (Lin et al., 2005). Human atrial myocytes containing sinus node were 
isolated from the aborted fetuses (14-19 weeks of gestation). These cells were injected into 
the left ventricles of pigs. After complete AV block was induced by catheter ablation, the 
idioventricular beat was detected near the injection site. Connexin 43 formed between the 
donor and recipient cells was identified, suggesting that the fetal myocytes are able to form 
gap junctions with the adult myocytes. Further, isoprenalin significantly increased the 
idioventricular rate (Lin et al., 2005). However, the limited source of pacing fetal myocytes 
and strong ethical concerns have hampered further development of the biological 
pacemaker using this approach for possible clinical application. 
5.2.2 Stem cell derived cardiomyocytes 
Rapid progress on recent studies of embryonic stem cell differentiation has prompted an 
idea of creating a biological pacemaker using human embryonic stem cells (hESC) - derived 
myocytes. Human embryonic stem cells have the ability of proliferation in culture and are 
able to differentiate into different cell types. Under certain conditions, hESC can be induced 
to differentiate into spontaneously beating cardiac myocytes expressing HCN channels but 
not Kir2.1 channels. Therefore, the hESC-converted-beating-myocytes are capable of 
creating a biological pacemaker within the ventricles. 
Human embryonic stem cells have been shown to differentiate into cardiac myocytes (He et 
al., 2003). Various action potentials similar to those recorded in the SA node, atrial, and 
ventricular myocytes have been observed (He et al., 2003). The isolated beating myocytes 
were shown to be able to functionally integrate into the neonatal rat ventricular myocytes to 
induce spontaneous rhythmic activity (Xue et al., 2005). The hESC-derived beating myocytes 
were implanted into the left ventricle of guinea pig to initiate the spontaneous action 
potentials in otherwise quiescent ventricular myocytes, recorded by both ECG and optical 
mapping technique. In the beating hESC-derived myocytes, If has been recorded and HCN2 
expression was detected (Satin et al., 2004). Consistently, the If driven pacemaker activity has 
also been observed in mouse ESC-derived beating myocytes (Abi-Gerges et al., 2000; Qu et 
al., 2008; Barbuti et al., 2009). Not surprisingly, in hESC-derived beating cardiomyocytes, the 
inward rectifier K+ current, IK1, and Kir2.1 protein expression were barely detected (Satin et 
al., 2004). In a swine AV block model, injection of these spontaneously beating hESC-derived 
myocytes into the left ventricle induced a long-lasting ectopic ventricular rhythm (Kehat et 
al., 2004). 
While hESCs-derived beating myocytes hold promises for creating a biological pacemaker, 
its use is not without risks. Potential tumorigenesis, immuno-reactivity, and pro-
arrhythmogenesis are major concerns (Gepstein, 2008). To bypass these concerns, adult 
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human mesenchymal stem cells have been used as an alternative strategy to deliver HCN 
genes to the ventricles. 
It has been demonstrated that adult human mesenchymal stem cells can form gap junctions 
with the ventricular myocytes in the co-culture (Valiunas et al., 2004). Using this property, 
HCN2 gene was introduced into the hMSC and via newly formed gap junctions to the 
coupled ventricular myocytes for triggering the spontaneous pacemaker activity in the host 
ventricular myocytes (Rosen et al., 2008; Valiunas et al., 2009).  
6. Optimization of biological pacemaker 
An effective biological pacemaker must meet the following minimal requirements: 1) a 
physiological heart rate that can change in response to metabolic needs, usually fulfilled via 
neurohumoral modulation, 2) the electrical integration of the donor cells with the host cells, 
3) the control of ionic currents only during diastole to avoid pro-arrhythmic potential. 
Gating of many cardiac ion channels is strongly dependent upon changes in membrane 
potential. HCN channels are activated at membrane hyperpolarization near diastolic 
potential, and are closed at membrane depolarization. Kir2.1 channels are not strongly 
dependent upon membrane potential. However, due to its inward rectifying property, 
Kir2.1 channels produce little currents in the voltage range from -40mV to 0mV. 
Cardiac ion channel properties can also be altered by protein expression levels and post-
translational modulation of the channel proteins at the plasma membrane. Signaling 
molecules such as norepinephrine, acetylcholine, adenosine, adenosine-5’- triphosphate 
(ATP) and cyclic adenosine monophosphate (cAMP) can all exert dramatic effects on ion 
channel functions. Sensitivity of the implanted biological pacemaker to cAMP is one of the 
requirements as the heart rate is modulated by β adrenergic receptor signaling pathway in 
which cAMP is the key signaling molecule.   
Advancement in the cell biology of ion channel has significantly advanced our 
understanding of how ion channel forward trafficking to the plasma membrane for cell 
surface expression can critically affect the function of ion channels. Recently, a variety of 
cells has been differentiated into spontaneously beating myocytes. The potential technical 
issues as how to use these cells for a working biological pacemaker must be addressed. 
6.1 Modulation of Kir2.x, HCN and Cx43 channel levels in the ventricle 
Whether gene- or cell-based approach, the essential working principle is the external control 
of the relative levels of outward (IK1) and inward (If) currents during diastole. Biophysics 
and molecular biology studies of IK1 and If in the past have significantly advanced our 
understanding how the Kir2.1 and HCN channels are modulated at the plasma membrane. 
More recently, microRNA studies have provided clues as how these channel transcripts are 
regulated. Enhanced understanding about regulation of Kir2.1 and HCN channel levels will 
offer new strategies to create in vivo biological pacemaker without the use of the full-length 
Kir2.1 and HCN channels. 
6.2 Gene regulation of channels by microRNA 
MicroRNAs (miRs) are small non-coding mRNA ~22nt in length. They bind to the 3’ 
untranslated region (3’-UTR) of the target genes and inhibit the transcription of the gene 
expression (Catalucci et al., 2009). Although the working mechanisms of the miRs are still 
poorly understood, recent works have demonstrated a significant potential of the 
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endogenous miRs in the treatment of heart diseases such as coronary artery disease and 
heart failure (Callis & Wang, 2008; van Rooij et al., 2008; Catalucci et al., 2009). The muscle 
specific forms of miR-1 and miR-133 have been demonstrated to be pivotal in the 
development of hypertrophy and arrhythmias (Care et al., 2007; Yang et al., 2007).  
Overexpression of miR-1 has been detected in individuals with coronary artery disease 
(Yang et al., 2007). Increased miR-1 has been shown to inhibit the gene expression of KCNJ2 
(which encodes Kir2.1 channel proteins) and GJA1 (which encodes connexin 43) (Yang et al., 
2007). In the infarct rat hearts, the reduced Kir2.1 and Cx43 channels were linked to the 
arrhythmogenic potential by slowing conduction and depolarization of the resting 
membrane potential. 
 On the other hand, decreased levels of both miR-1 and miR-133 have been shown to 
enhance the HCN2/HCN4 protein expression and functional channels at the plasma 
membrane (Xiao et al., 2007). These results suggested that regulation of Kir2.1, Cx3.2, and 
HCN gene expression by microRNAs may represent an alternative strategy for creation of a 
biological pacemaker. 
6.3  Regulation of channel surface expression 
The number of functional channels at the plasma membrane determines the contribution of 
current to the membrane potential. Decreased IK1 (Beuckelmann et al., 1993; Kaab et al., 
1996), reduced number of Cx32 channels (Severs, 1994, 2002), and increased If as well as the 
number of HCN channels (Cerbai et al., 1997; Hoppe et al., 1998; Cerbai et al., 2001; Stillitano 
et al., 2008) have been reported in heart diseases such as ischemia and heart failure. Gene 
therapy aims primarily to change the number of functional channels. On the other hand, 
surface expression of ion channels can be regulated by endogenous mechanisms. 
In the past ten years, surface expression of the ion channel has been realized as one of the 
effective ways to alter the function of ion channels. Molecular mechanisms that control the 
synthesized proteins to exit the endoplasmic reticulum (ER), move forward to the Golgi 
apparatus, and to the plasma membrane have been intensively investigated, particularly for 
potassium channel membrane trafficking. Defective membrane trafficking due to mutated 
Kir2.1/HCN channels has been linked to cardiac arrhythmias (Dhamoon & Jalife, 2005; 
Herrmann et al., 2007; Baruscotti et al., 2010). Furthermore, endogenous proteins, such as 
small GTPase Rho1/Rac1, have been found to modulate Kir2.1 surface expression (Boyer et 
al., 2009).  
We have recently discovered that tyrosine phosphorylation of HCN channels mediated by 
Src kinases and receptor protein tyrosine phosphatase alpha can significantly alter the 
surface expression of HCN2/HCN4 channels (Huang et al., 2008; Lin et al., 2009). The 
surface expression and current density of HCN2/HCN4 channels are increased via 
enhanced tyrosine phosphorylation mediated by Src kinases, and decreased through 
tyrosine dephosphorylation by RPTPα (Huang et al., 2008; Lin et al., 2009). Using this 
modulation mechanism, we have shown that Src kinases can restore the normal current and 
surface expression of a human HCN4 mutant with defective membrane trafficking (Lin et al., 
2009).  
Future investigation of how the membrane trafficking of Kir2.1, HCN, and Cx43 channels 
are affected under pathologic conditions may provide novel strategies for efficiently 
controlling the pacemaker activity in the ventricle when the sinus node is dysfunctional. 
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6.4 Isolation of homogeneous ESCs-derived beating cardiomyocytes 
In theory, ESC derived cardiomyocytes have the potential for arrhythmogenesis (Zhang et 
al., 2002). At least three different types of action potentials have been recorded in 
cardiomyocytes derived from ESCs: the sinus node like spontaneously pacing action 
potential, the atrial like action potential with narrow action potential duration, and the 
ventricular like action potential. 
Although SA node markers such as Cx45/Cx40 and HCN4 have been used to label SA node 
cells, it will remain a technical challenge to isolate “pure” ESCs derived cardiomyocytes that 
only exhibit the SA node like action potential. Inclusion of any other types of myocytes in 
the cell grafts will increase the arrhythmic risk to the host cells. In early-stage of cardiac 
development, HCN4 is also abundantly expressed in ventricular myocytes (Stieber et al., 
2003). More specific markers for SA node will facilitate the isolation of pure ESCs derive 
cardiomyocytes exhibiting SA node action potentials. 
If ESCs-derived cardiomyocytes do express Cx45, an additional challenge would be the 
properties of possible heteromeric gap junction channels formed by Cx45 and Cx43 in the 
host ventricular myocytes. A potential solution can be a genetically modified ESC cell body 
that has suppressed Cx45 and enhanced the expression of Cx43. 
6.5 Resources of stem cells for generation of beating cardiomyocytes 
The main concerns for the use of hESC are the ethical issues, the anticipated immune 
rejection and the oncogenic risk. In 2006, mouse fibroblasts were reprogrammed by 
expression of four transcription factors (oct4, sox2, c-myc, and klf4) to produce cells with 
characteristics similar to those of the mouse ESCs including the most important pluripotent 
property (Takahashi & Yamanaka, 2006). These inducible pluripotent stem cells (iPSCs) can 
also differentiate into cardiomyocytes. In the human iPSCs derived beating myocytes, 
connexin 43 and HCN2 expression were detected (Zwi et al., 2009). However, no Kir2.x 
expression was reported. The electrical properties of human iPSCs support the notion that 
the human iPSCs derived myocytes may represent a better choice than the hESCs derived 
myocytes for creation of a biological pacemaker. 
6.6 Brown adipose tissue 
Recently, Takahashi et al has reported the use of brown adipose tissue to create pacemaker 
like myocytes (Takahashi et al., 2009). Brown adipose tissue (BAT) is one type of 
mesenchymal stem cells that have the potential to differentiate into several types of cells. 
Cultured cells isolated from the brown adipose tissue expressed key marker genes for 
cardiac conduction and pacemaker activity, such as connexins 40 and 45 (Cx40 and Cx45), 
and HCN1 to HCN4. These BAT-converted pacing cells were injected into the area around 
AV node of mice. After one week, complete AV block was improved in 50% of mice tested. 
Although this work is significant in terms of sources for biological pacemaker, the 
electrophysiology of these BAT-converted pacing cells is unclear. It was not reported 
whether an If-like current is present, IK1-like current is absent or the gap junctions can be 
formed by the donor and recipients cells. 
6.7 Mesoangioblasts 
Mesoangioblasts (MABs) have been recently discovered as multipotent and self-renewing 
cells isolated from the aorta (Minasi et al., 2002). MABs are also found in the small vessels of 
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the mouse heart ventricle (Galvez et al., 2008). A recent report showed that MABs can be 
converted into SAN-like pacing myocytes (Barbuti et al., 2010). The MABs-derived myocytes 
expressed several proteins that characterize the pacemaker cells, such as HCN4 channels 
and connexin 45. Aggregates of these cells display stable pacemaker activity characterized 
by SAN-like action potential showing distinct phase-4 depolarization with the most negative 
potential around -60mV. These cells also exhibited an If-like current with threshold 
activation near -50mV and reversal potential around -20mV. In addition, there is also no IK1 
in these myocytes.  
Further, the pacemaker activity exhibited in these cells is modulated by neurotransmitters. 
Isoproterenol accelerated, while acetylcholine slowed down the action potentials (Barbuti et 
al., 2010). These observations recapitulated the autonomous modulation of pacemaker 
activity in the SA node. These properties make MABs an alternative source for creation of 
biological pacemaker. It would be interesting to see whether MABs can induce an escape 
ventricular rhythm after being injected into the left ventricle of the heart in a large animal 
model such as canine or porcine. 
6.8 Global gene transfer and electrical integration 
It is known that cardiac ion channels are non-uniformly distributed in different regions of 
the heart. While the differential expression of ion channels is necessary for physiological 
heart function, it could also contribute to the pathologic genesis of electrophysiology under 
pathological conditions. In a neonatal rat ventricular myocyte monolayer model, IK1 
heterogeneity has been shown to contribute to the generation of ventricular arrhythmias 
(Sekar et al., 2009). Therefore, local gene transfer by injection not only is inefficient in terms 
of pacing the whole ventricle, but it could also be pro-arrhythmic. Recently, an improved 
approach for global gene transfer has been reported (Kikuchi et al., 2005). In an effort to 
modify atrial electrophysiology without affecting ventricular function in atrial fibrillation, 
Kikuchi et al applied adenovirus containing HERG-G628S, a long-QT syndrome mutant, 
directly to the epicardial surface of the porcine atria, by using poloxamer gel to increase 
virus contact time, followed by using mild trypsin to increase virus penetration. The results 
showed a prolonged action potential duration and refractory period without changes in 
ventricular electrophysiology (Kikuchi et al., 2005). 
Membrane stability, diastolic depolarizing current and gap junction channels are the 
minimal requirement for an effective biological pacemaker that can pace the otherwise 
quiescent ventricles by electrically integrating the donor cells with the host cells. Without 
electrical integration, the donor cells can provoke the unwanted side effects, even the 
contractile performance can be improved. Clinical trial with skeletal myoblast has shown a 
high incidence of ventricular arrhythmias (Smits et al., 2003). The possible reason is due to 
the lack of gap junction channels formed between the donor skeletal myoblasts and the 
ventricular myocytes, as skeletal muscle cells are electrically isolated without gap junction 
channels (Leobon et al., 2003; Abraham et al., 2005).  
7. Summary 
Cardiac arrhythmias have remained as the leading cause of mortality and morbidity in the 
developed countries and now also become a major public health problem in the developing 
countries. Electronic pacemaker has been working well and remains the industry standard. 
Numerous pharmacological tools have been developed to treat arrhythmias. However, due 
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to the intrinsic limitations in each strategy, there is still a strong need for novel strategy to 
normalize these rhythmic disorders with fewer side effects. Advances in gene and cell 
therapy have made it possible for creation of a biological pacemaker that will be used to 
overcome the limitations of electronic pacemaker. While there are still many obstacles for an 
effective and long-lasting biological pacemaker, development of new technologies and more 
animal experiments for enhanced understanding of mechanisms that control the gene 
expression and coupling between the donor and host cells will make the use of biological 
pacemaker a clinical reality.  
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